Organigram Expands Edison Portfolio With Three New Indica Genetics – Black Cherry Punch, Ice Cream Cake (I.C.C.), & Slurric...
December 22 2020 - 6:00AM
Business Wire
Edison dried flower portfolio continues to
thrive with ongoing investment in genetics program and
micro-climate management
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, is pleased to announce the
launch of three new Edison Cannabis Co. (“Edison”) Indica strains
including high potency Black Cherry Punch and Ice Cream Cake
(I.C.C.) and full flavour Slurricane.
All three on-trend dried flower Edison products offer a distinct
flavour and aroma profile as a result of being grown in a strain
specific micro-climate. These include:
- Black Cherry Punch: Black Cherry Punch’s sweet and
floral undertones balance its fruity flavour and aroma. Its
crown-shaped flowers are medium in size with emerald green and
purple buds that are crystal rich with trichomes. This strain
boasts dominant terpenes including Limonene, β-Caryophyllene,
Linalool, Myrcene, and β-Pinene and a THC range of 20%-26%.
- Ice Cream Cake (I.C.C.): ICC is bold and complex. This
strain pairs 20%-26% THC with sweet, spicy, and savoury flavours.
Its strong notes of gasoline are balanced with undertones of clove
and sage. The strains dominant terpenes include Limonene,
β-Caryophyllene, Germacrene B Linalool and α-Pinene. Equally as
bold in appearance, its dense, dark green buds are contrasted by an
abundance of copper-coloured pistils.
- Slurricane: Slurricane couples full flavour with a
strong 17%+ THC. It has rich notes of blueberries and cream with
nutty, floral undertones. This strain’s dominant terpenes include
β-Caryophyllene, Germacrene B, α-Humulene, Myrcene. The strain’s
buds are frosted with trichomes and deep purple in colour,
contrasted by interwoven orange pistils.
The new strains are expected to be available shortly in 3.5g
formats in certain provincial retail stores.
“A relentless commitment to science, data and quality continues
to be the hallmark of the Edison brand,” says Greg Engel, CEO,
Organigram. “We are pleased and proud to introduce these three new
strains to the Canadian market and hope adult consumers enjoy the
unique flavours each one has to offer.”
Also available to patients under Organigram’s medical brand, the
new strains will be known as Purple Violet (Black Cherry Punch),
Mayflower (Ice Cream Cake) and Elephant Rock (Slurricane).
Genetics + Environment = Phenotype Every Edison strain
benefits from being grown in one of over 100 data-backed,
strain-specific grow rooms with micro-climates designed to ensure
consistent quality. Variables including humidity, temperature,
light and plant density can be customized to optimize the growth
and output of each plant.
The new Edison strains are also a product of the Company’s
ongoing genetic exploration program. Black Cherry Punch, Ice Cream
Cake (I.C.C.) and Slurricane are among the strains developed from
genetics Organigram originally sourced from a premium cannabis
nursery. The nursery's processes and technology help eliminate
disease and pests from the plants in order to produce a high
quality genetic product.
“At Organigram, our attention to both the genetics of the plant
and the environment in which it is grown result in a unique
phenotype expression. This means even plants grown from the same
genetics can be markedly different based on their growing
conditions. This can include important variations such as the
physical properties, potency, and kinds of terpenes and aromas
found in the plant,” says Engel. “This kind of strategic and
creative product development process is a key differentiator for
both the Edison portfolio and the Company overall; delivering
exceptional products is the core of our business.”
About Organigram Holdings Inc. Organigram Holdings Inc.
is a NASDAQ Global Select and TSX listed company whose wholly owned
subsidiary, Organigram Inc., is a licensed producer of cannabis and
cannabis-derived products in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics, SHRED and Trailblazer.
Organigram's facility is located in Moncton, New Brunswick and the
Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
timing for availability of products in the market, consumer
acceptance of products, factors and risks as disclosed in the
Company’s most recent annual information form, management’s
discussion and analysis and other Company documents filed from time
to time on SEDAR (see www.sedar.com) and filed or furnished to the
Securities and Exchange Commission on EDGAR (see www.sec.gov).
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this
press release. Although the Company believes that the assumptions
and factors used in preparing the forward-looking information in
this news release are reasonable, undue reliance should not be
placed on such information and no assurance can be given that such
events will occur in the disclosed time frames or at all. The
forward-looking information included in this news release are made
as of the date of this news release and the Company disclaims any
intention or obligation, except to the extent required by law, to
update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201222005142/en/
For Investor Relations enquiries: Amy Schwalm Vice President,
Investor Relations amy.schwalm@organigram.ca (416) 704-9057
For Media enquiries: Marlo Taylor
mtaylor@gagecommunications.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024